Paper28058014
Anti-viral role of toll like receptor 4 in hepatitis B virus infection: An in vitro study.
Das D and 9 others. World J Gastroenterol, 2016. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Anti-viral role of toll like receptor 4 in hepatitis B virus infection: An in vitro study. Papers, record 28058014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28058014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anti-viral role of toll like receptor 4 in hepatitis B virus infection: An in vitro study.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepacivirus | Major topic |
| Hepatitis B, Chronic | Major topic |
| Hepatocytes | Major topic |
| Toll-Like Receptor 4 | Major topic |
| Active Transport, Cell Nucleus | |
| Cellular Microenvironment | |
| DNA Methylation | |
| DNA, Viral | |
| Dose-Response Relationship, Drug | |
| Epigenesis, Genetic | |
| G1 Phase Cell Cycle Checkpoints | |
| Hep G2 Cells | |
| Host-Pathogen Interactions | |
| Humans | |
| Ligands | |
| Lipopolysaccharides | |
| NF-kappa B | |
| Signal Transduction | |
| Time Factors | |
| Viral Load |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22330637 | Increased hepatic expression of TLR2 and TLR4 in the hepatic inflammation-fibrosis-carcinoma sequence. | Innate Immun | 2012 | https://conductscience.org/library/papers/22330637 | PubMed |
| 2 | 20852130 | miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. | Blood | 2010 | https://conductscience.org/library/papers/20852130 | PubMed |
| 3 | 16936740 | RB and cell cycle progression. | Oncogene | 2006 | https://conductscience.org/library/papers/16936740 | PubMed |
| 4 | 26442981 | Stabilization of SIRT7 deacetylase by viral oncoprotein HBx leads to inhibition of growth restrictive RPS7 gene and facilitates cellular transformation. | Sci Rep | 2015 | https://conductscience.org/library/papers/26442981 | PubMed |
| 5 | 12717385 | Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. | Hepatology | 2003 | https://conductscience.org/library/papers/12717385 | PubMed |
| 6 | 24025329 | Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID). | J Biol Chem | 2013 | https://conductscience.org/library/papers/24025329 | PubMed |
| 7 | 15014185 | Hepatitis B virus infection--natural history and clinical consequences. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15014185 | PubMed |
| 8 | 20690823 | Genomes in conflict: maintaining genome integrity during virus infection. | Annu Rev Microbiol | 2010 | https://conductscience.org/library/papers/20690823 | PubMed |
| 9 | 17176475 | Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell. | Cell Div | 2006 | https://conductscience.org/library/papers/17176475 | PubMed |
| 10 | 27253403 | TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK-STAT signaling pathway. | Cell Death Dis | 2016 | https://conductscience.org/library/papers/27253403 | PubMed |
| 11 | 25733157 | The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection. | J Hepatol | 2015 | https://conductscience.org/library/papers/25733157 | PubMed |
| 12 | 26389938 | Alterations of Nuclear Architecture and Epigenetic Signatures during African Swine Fever Virus Infection. | Viruses | 2015 | https://conductscience.org/library/papers/26389938 | PubMed |
| 13 | 17929296 | Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. | Hepatology | 2007 | https://conductscience.org/library/papers/17929296 | PubMed |
| 14 | 26514586 | Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling. | BMC Cancer | 2015 | https://conductscience.org/library/papers/26514586 | PubMed |
| 15 | 15890966 | Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. | J Virol | 2005 | https://conductscience.org/library/papers/15890966 | PubMed |
| 16 | 26045709 | Saturated Fatty Acid inhibits viral replication in chronic hepatitis B virus infection with nonalcoholic Fatty liver disease by toll-like receptor 4-mediated innate immune response. | Hepat Mon | 2015 | https://conductscience.org/library/papers/26045709 | PubMed |
| 17 | 12855817 | Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. | Science | 2003 | https://conductscience.org/library/papers/12855817 | PubMed |
| 18 | 17644211 | Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. | J Hepatol | 2007 | https://conductscience.org/library/papers/17644211 | PubMed |
| 19 | 25720442 | Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP-β in hepatocytes. | J Viral Hepat | 2015 | https://conductscience.org/library/papers/25720442 | PubMed |
| 20 | 27227879 | Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling. | PLoS One | 2016 | https://conductscience.org/library/papers/27227879 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42922067 | Experimental and Pharmacoinformatic Studies Reveal Allium cepa L. Extract-Mediated Modulation of Hepatitis B Virus Associated Inflammatory Pathways via Quercetin Glucoside Derivatives. | Chem Biodivers | 2026 | https://conductscience.org/library/papers/42922067 | PubMed |
| 41869349 | Innate immune recognition and evasion strategies of hepatitis B virus: from DNA to RNA and viral proteins. | Front Immunol | 2026 | https://conductscience.org/library/papers/41869349 | PubMed |
| 34950433 | Novel roles of lipopolysaccharide and TLR4/NF-κB signaling pathway in inflammatory response to liver injury in Budd-Chiari syndrome. | World J Gastrointest Surg | 2021 | https://conductscience.org/library/papers/34950433 | PubMed |
| 34803956 | Host Innate Immunity Against Hepatitis Viruses and Viral Immune Evasion. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34803956 | PubMed |
| 33329547 | Multi-Omic Data Integration Allows Baseline Immune Signatures to Predict Hepatitis B Vaccine Response in a Small Cohort. | Front Immunol | 2020 | https://conductscience.org/library/papers/33329547 | PubMed |
Genes34
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28058014
GET https://conductscience.org/api/papers/v1/28058014/references?page=2